Kirkwood JM, Del Vecchio M, Weber J, Hoeller C, et al. Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial. Nat Med 2023 Nov 3. doi: 10.1038/s41591-023-02661.
PMID: 37923838